Cargando…

Changes in Levels of Biomarkers Associated with Adipocyte Function and Insulin and Glucagon Kinetics During Treatment with Dapagliflozin Among Obese Type 2 Diabetes Mellitus Patients

OBJECTIVES: This study aimed to investigate changes in levels of biomarkers associated with adipocyte function and insulin and glucagon kinetics after a meal tolerance test (MTT) during treatment with dapagliflozin among obese type 2 diabetes mellitus (T2DM) patients. METHODS: T2DM patients with hem...

Descripción completa

Detalles Bibliográficos
Autores principales:	Okamoto, Aki, Yokokawa, Hirohide, Sanada, Hironobu, Naito, Toshio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2016
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045829/ https://www.ncbi.nlm.nih.gov/pubmed/27333994 http://dx.doi.org/10.1007/s40268-016-0137-9

Ejemplares similares

Dipeptidyl Peptidase-4 Inhibitor (Vildagliptin) Improves Glycemic Control After Meal Tolerance Test by Suppressing Glucagon Release
por: Okamoto, Aki, et al.
Publicado: (2014)

Efficacy and safety of semaglutide in glycemic control, body weight management, lipid profiles and other biomarkers among obese type 2 diabetes patients initiated or switched to semaglutide from other GLP-1 receptor agonists
por: Okamoto, Aki, et al.
Publicado: (2021)

Association between health literacy and metabolic syndrome or healthy lifestyle characteristics among community-dwelling Japanese people
por: Yokokawa, Hirohide, et al.
Publicado: (2016)

Achievement of Target Blood Pressure Levels among Japanese Workers with Hypertension and Healthy Lifestyle Characteristics Associated with Therapeutic Failure
por: Kudo, Nagako, et al.
Publicado: (2015)

Changes in antidiabetic prescription patterns and indicators of diabetic control among 200,000 patients over 13 years at a single institution in Japan
por: Fujibayashi, Kazutoshi, et al.
Publicado: (2016)

Achievement of target blood pressure among community residents with hypertension and factors associated with therapeutic failure in the northern territory of Japan
por: Yokokawa, Hirohide, et al.
Publicado: (2022)

An association between visceral or subcutaneous fat accumulation and diabetes mellitus among Japanese subjects
por: Yokokawa, Hirohide, et al.
Publicado: (2021)

Association between high cystatin C levels and carotid atherosclerosis
por: Kobayashi, Toshiyuki, et al.
Publicado: (2017)

Effects of Sitagliptin on Insulin and Glucagon Levels in Type 2 Diabetes Mellitus
por: Kim, Ji Hyun
Publicado: (2015)

Association between serum uric acid levels and achievement of target blood pressure among Japanese community residents with hypertension
por: Yokokawa, Hirohide, et al.
Publicado: (2023)

Dapagliflozin as an adjunct therapy to insulin in the treatment of patients with type 1 diabetes mellitus
por: Tamez, Hector E., et al.
Publicado: (2015)

Achievement of Target Serum Uric Acid Levels and Factors Associated with Therapeutic Failure among Japanese Men Treated for Hyperuricemia/Gout
por: Katayama, Akiko, et al.
Publicado: (2019)

Useful Predictive Factors for Bacteremia among Outpatients with Pyelonephritis
por: Nakamura, Nobuhiro, et al.
Publicado: (2018)

A New Influenza-Tracking Smartphone App (Flu-Report) Based on a Self-Administered Questionnaire: Cross-Sectional Study
por: Fujibayashi, Kazutoshi, et al.
Publicado: (2018)

Assessing lifestyle-related diseases with body and muscle mass using bioelectrical impedance analysis
por: Miyagami, Taiju, et al.
Publicado: (2020)

Mathematical Model of Glucagon Kinetics for the Assessment of Insulin-Mediated Glucagon Inhibition During an Oral Glucose Tolerance Test
por: Morettini, Micaela, et al.
Publicado: (2021)

Serum zinc concentrations and characteristics of zinc deficiency/marginal deficiency among Japanese subjects
por: Yokokawa, Hirohide, et al.
Publicado: (2020)

An association between subcutaneous fat mass accumulation and hypertension
por: Goto, Kento, et al.
Publicado: (2021)

Glucagon Test Is a Useful Predictor of Withdrawal From Insulin Therapy in Subjects With Type 2 Diabetes Mellitus
por: Iwamoto, Yuichiro, et al.
Publicado: (2022)

Dapagliflozin stimulates glucagon secretion at high glucose: experiments and mathematical simulations of human A-cells
por: Pedersen, Morten Gram, et al.
Publicado: (2016)

Insulin dose reduction in dapagliflozin combination therapy for type 1 diabetes mellitus: the RISING-STAR study
por: Hamaguchi, Masahide, et al.
Publicado: (2022)

The waist circumference-adjusted associations between hyperuricemia and other lifestyle-related diseases
por: Miyagami, Taiju, et al.
Publicado: (2017)

Association between Visceral or Subcutaneous Fat Accumulation and B-Type Natriuretic Peptide among Japanese Subjects: A Cross-Sectional Study
por: Hayashi, Yoshinori, et al.
Publicado: (2021)

Association between Dapagliflozin, Cardiac Biomarkers and Cardiac Remodeling in Patients with Diabetes Mellitus and Heart Failure
por: Xanthopoulos, Andrew, et al.
Publicado: (2023)

Postprandial Plasma Glucagon Kinetics in Type 2 Diabetes Mellitus: Comparison of Immunoassay and Mass Spectrometry
por: Katahira, Takehiro, et al.
Publicado: (2018)

Coagonist of glucagon-like peptide-1 and glucagon receptors ameliorates kidney injury in murine models of obesity and diabetes mellitus
por: Patel, Vishal J, et al.
Publicado: (2018)

Dapagliflozin Does Not Modulate Atherosclerosis in Mice with Insulin Resistance
por: Taberner-Cortés, Alida, et al.
Publicado: (2020)

Current perspective on the role of insulin and glucagon in the pathogenesis and treatment of type 2 diabetes mellitus
por: Ojha, Ashutosh, et al.
Publicado: (2019)

Insulin and Glucagon: Partners for Life
por: Holst, Jens Juul, et al.
Publicado: (2017)

The Role of Nrf2: Adipocyte Differentiation, Obesity, and Insulin Resistance
por: Seo, Hyun-Ae, et al.
Publicado: (2013)

Dapagliflozin: Cardiovascular Safety and Benefits in Type 2 Diabetes Mellitus
por: Saleem, Fatima
Publicado: (2017)

Efficacy of Dapagliflozin Combined with Lifestyle Intervention in Obesity Control
por: Dai, Wenhui, et al.
Publicado: (2022)

Comparison of Serum Ketone Levels and Cardiometabolic Efficacy of Dapagliflozin versus Sitagliptin among Insulin-Treated Chinese Patients with Type 2 Diabetes Mellitus
por: Lee, Chi-Ho, et al.
Publicado: (2022)

Directing visceral white adipocyte precursors to a thermogenic adipocyte fate improves insulin sensitivity in obese mice
por: Hepler, Chelsea, et al.
Publicado: (2017)

Glucagon and insulin have opposite effects on tissue chromium distribution in an obese mouse model
por: Lin, Chang, et al.
Publicado: (2013)

Effect of Dietary Macronutrients on Postprandial Glucagon and Insulin Release in Obese and Normal-Weight Women
por: Wikarek, Tomasz, et al.
Publicado: (2020)

The Relationships between Metabolic Disorders (Hypertension, Dyslipidemia, and Impaired Glucose Tolerance) and Computed Tomography-Based Indices of Hepatic Steatosis or Visceral Fat Accumulation in Middle-Aged Japanese Men
por: Fujibayashi, Kazutoshi, et al.
Publicado: (2016)

Effıcacy and safety of dapagliflozin on diabetic patients receiving high-doses of insulin
por: Sertbas, Meltem, et al.
Publicado: (2019)

Dapagliflozin's effect on serum homocysteine in patients with hypertension complicated with insulin resistance
por: Yu, Xiaoqian, et al.
Publicado: (2023)

Changes in glucagon kinetics and processing in patients with acute pancreatitis
por: Tanjoh, K, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_hdkb9eku2thhpmt9fop08n984d